Strategic partnerships IB has a history of collaborating with major players in imaging and healthcare, including Mayo Clinic, NIH funding, GE Healthcare, and Prism Clinical Imaging. This indicates strong potential to engage with large health systems and imaging networks through partnerships or co-development opportunities.

Clinical workflow integration The company develops ready-to-use software with a client-centric approach aimed at researchers and clinicians. Target opportunities exist in integrating IB Clinic and related tools into existing hospital PACS, imaging informatics, and research workflows to accelerate adoption.

Research to commercialization Past NIH funding and collaborations suggest strong capabilities in translating research into market-ready software. This presents opportunities to pursue funded projects, pilots, or enterprise licenses with research institutions and healthcare networks.

Niche capability Focused on brain imaging analytics and lesion tracking platforms (e.g., IB Trax) with Mayo Clinic collaboration points to a defensible niche. Sales efforts can emphasize specialized analytics, accuracy, and workflow relevance to neuroimaging departments.

Growth through scale Recent partnerships with large entities and a channel through IQ-AI Ltd hint at scalable distribution paths. Identify enterprise-level customers and regional health system networks where a combined offering with imaging analytics can drive efficiency and research outcomes.